Trontinemab Trial: UK Patients Among First to Test Alzheimer’s Prevention Drug
UK patients are among the first in Europe to participate in a phase III Alzheimer’s trial testing Trontinemab, an experimental drug targeting amyloid plaques in asymptomatic…